Covered recipient · General Payments record
VICTORIA L KINSEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2022
$527.16
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $253.79 | 20 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $146.80 | 13 |
| Novo Nordisk AS | $71.31 | 5 |
| Lundbeck LLC | $23.43 | 1 |
| Acerta Pharma LLC | $12.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.25 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075187 | CMS |
| ABBVIE INC. | $7.39 | 03/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075189 | CMS |
| ABBVIE INC. | $10.17 | 03/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075191 | CMS |
| ABBVIE INC. | $17.37 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075193 | CMS |
| ABBVIE INC. | $9.18 | 05/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075195 | CMS |
| ABBVIE INC. | $15.23 | 05/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075197 | CMS |
| ABBVIE INC. | $9.03 | 06/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075199 | CMS |
| ABBVIE INC. | $16.94 | 06/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075201 | CMS |
| ABBVIE INC. | $4.36 | 06/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075203 | CMS |
| ABBVIE INC. | $4.11 | 06/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075205 | CMS |
| ABBVIE INC. | $15.20 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075207 | CMS |
| ABBVIE INC. | $7.31 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075209 | CMS |
| ABBVIE INC. | $22.26 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893075211 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.25 | 08/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915097477 | CMS |
| Lundbeck LLC | $23.43 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945767399 | CMS |
| Novo Nordisk Inc | $15.87 | 02/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899416475 | CMS |
| Novo Nordisk Inc | $14.05 | 03/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898946857 | CMS |
| Novo Nordisk Inc | $15.53 | 06/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898578687 | CMS |
| Novo Nordisk Inc | $12.36 | 09/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898849775 | CMS |
| Novo Nordisk Inc | $13.50 | 11/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898897139 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.